Our thoughts are with those who have lost a loved one ...
Infex Therapeutics announces positive phase IIa study results for RESP-X in NCFB patients colonised with Pseudomonas aeruginosa: Cheshire, UK Saturday, May 23, 2026, 18:00 Hrs [IS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results